Application of anti-programmed cell death protein 1 antibody in children with refractory or relapsed Hodgkin lymphoma
Objective: To explore the efficacy of anti-programmed cell death protein 1 (PD-1) antibody for children with refractory or relapsed Hodgkin lymphoma. Methods: Clinical data including short-term efficacy, long-term efficacy and adverse reaction of Hodgkin lymphoma children treated with anti-PD-1 anti...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 60(2022), 6 vom: 02. Juni, Seite 573-577
|
|---|
| 1. Verfasser: |
Li, Y
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Duan, Y L,
Huang, M,
Zhang, L,
Jin, Y G,
Zhang, X L,
Wang, Xiaoling |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | Chinese |
|---|
| Veröffentlicht: |
2022
|
|---|
| Zugriff auf das übergeordnete Werk: | Zhonghua er ke za zhi = Chinese journal of pediatrics
|
|---|
| Schlagworte: | Journal Article
Programmed Cell Death 1 Receptor |
|---|